FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
+5.92%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$456M
AUM Growth
+$456M
(+28%)
Cap. Flow
+$83.2M
Cap. Flow
% of AUM
18.25%
Top 10 Holdings %
Top 10 Hldgs %
84.89%
Holding
24
New
7
Increased
7
Reduced
2
Closed
1
Top Buys
1 |
Arcus Biosciences
RCUS
|
$42.1M |
2 |
CBAY
Cymabay Therapeutics
CBAY
|
$12.5M |
3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$9.48M |
4 |
AKAO
Achaogen, Inc.
AKAO
|
$6.15M |
5 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$5.42M |
Top Sells
1 |
Wave Life Sciences
WVE
|
$3.5M |
2 |
Ascendis Pharma
ASND
|
$2.24M |
3 |
Pacific Biosciences
PACB
|
$1.18M |
Sector Composition
1 | Healthcare | 53.55% |